Changes in ribonucleic acid degrading enzymes in ehrlich ascites cells during growth and after actinomycin D treatment.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology* / Q000473:pathology; D002477:Cells / Q000254:growth & development; D003609:Dactinomycin / Q000494:pharmacology; D006147:Guanine / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012260:Ribonucleases / Q000037:antagonists & inhibitors / Q000378:metabolism*
D002247:Carbon Isotopes; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003609:Dactinomycin; D006147:Guanine; D012260:Ribonucleases; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases; D010727:Phosphoric Diester Hydrolases; D007930:Leucine